65 yr female with breathing difficulty ecg showing atrial fibrillation with rapid ventricular response and st&t wave abnormality

Reading File

Finding Sources

Searching PubMed

"atrial fibrillation" AND "rate control" AND "acute management"

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

I now have comprehensive information to provide a thorough clinical response. Let me compile it all.

Clinical Assessment: 65F with Dyspnea + AF with RVR + ST-T Changes

Initial Stabilization Priority

Before any rhythm/rate intervention — ask: Is the tachycardia primary or reactive?

In a patient presenting with dyspnea and rapid AF, the initial evaluation must determine whether the rapid ventricular rate is the cause of the distress or a response to another underlying hemodynamic stress. Causes include:

Acute decompensated heart failure
Pulmonary embolism
Sepsis
Severe hypovolemia
Cardiac tamponade

Failure to identify an underlying cause of tachycardia may result in counterproductive attempts at rate control or cardioversion. (Rosen's Emergency Medicine)

ECG Interpretation

ECG Finding	Significance in This Patient
AF with RVR (rate usually >100–150 bpm)	Loss of atrial contribution to LV filling → may precipitate or worsen pulmonary edema
ST-T wave abnormalities	May indicate: (1) rate-related ischemia/demand ischemia, (2) ACS triggering AF, (3) LVH strain, (4) rate-related repolarization changes — must differentiate

Critical: ST-T changes in the setting of AF with RVR can be rate-related (resolve with rate control) or indicate true ACS. Obtain troponins and serial ECGs.

Immediate Assessment

History & Examination

Duration of AF (< or >48 hours — critical for cardioversion risk)
Prior AF history, medications, anticoagulation status
Signs of hemodynamic instability: hypotension, altered consciousness, pulmonary edema, chest pain
Signs of heart failure: elevated JVP, S3 gallop, crackles, bilateral leg edema

Investigations (simultaneous with management)

12-lead ECG (confirm AF, assess ST changes in multiple leads)
Troponin I/T (serial — r/o ACS as precipitant)
CXR (pulmonary congestion, cardiomegaly)
Echo (LV function, valvular disease, effusion — urgent if unstable)
BNP/NT-proBNP (heart failure severity)
CBC, BMP, Mg²⁺ (electrolytes — hypokalemia/hypomagnesemia promote AF)
TSH (hyperthyroidism — causes AF)
D-dimer / CT-PA if PE suspected
ABG if severe respiratory distress

Hemodynamic Status Assessment

UNSTABLE (hypotension, severe pulmonary edema, altered consciousness, ongoing ischemia)

→ Immediate synchronized DC cardioversion (100–200 J biphasic)

If AF duration >48 hours or unknown and no anticoagulation: give a DOAC dose or LMWH before or immediately after cardioversion if feasible; ideally TEE first if logistically possible
Treat underlying cause simultaneously

STABLE

→ Proceed with rate control, then address rhythm and anticoagulation

Rate Control (Stable Patient)

Target ventricular rate: ≤100–120 bpm (AHA)

Drug	Dose	Considerations
IV Diltiazem (preferred for rapid rate control)	0.25 mg/kg IV over 2 min; may repeat 0.35 mg/kg in 15 min; infusion 5–15 mg/hr	Avoid if significant LV systolic dysfunction (EF <40%), hypotension, WPW
IV Metoprolol	2.5–5 mg IV bolus over 2 min; may repeat up to 3 doses	Avoid in acute decompensated HF, reactive airway disease
IV Amiodarone	150 mg IV over 10 min, then 1 mg/min × 6 hr, then 0.5 mg/min × 18 hr	Preferred if LV dysfunction / HFrEF; also has cardioversion potential
Digoxin	0.25–0.5 mg IV, repeat q4–6h (total 1–1.5 mg/24h)	Slow onset; useful in HF with reduced EF; avoid if pre-excitation

Key rule: AV nodal agents (diltiazem, verapamil, beta-blockers, digoxin) are contraindicated in WPW/pre-excitation with AF — they may accelerate accessory pathway conduction and precipitate VF. (Rosen's Emergency Medicine)

If AF + HFrEF (EF <40%): Avoid diltiazem/verapamil. Use amiodarone or digoxin for acute rate control; beta-blockers should be avoided until hemodynamically stable.

ST-T Changes — Workup Decision

Rate-related repolarization changes: ST depression in multiple leads at rapid rates — expected; should improve once rate is controlled
Demand ischemia: Tachycardia increasing O₂ demand — usually diffuse ST changes, troponin may rise mildly
ACS triggering AF: Focal ST changes (e.g., inferior or anterior), troponin positive → activate ACS protocol, consider cardiology consult for angiography

If troponin is positive and/or ST changes are focal/persistent after rate control → manage as ACS (aspirin, anticoagulation, cardiology consult for PCI evaluation).

Anticoagulation & Stroke Prevention

Acute Setting

If AF duration <48 hours and cardioversion planned: can proceed; still give anticoagulation
If AF duration >48 hours or unknown: anticoagulate for 3–4 weeks before elective cardioversion, OR perform TEE to exclude LA thrombus before urgent cardioversion

CHA₂DS₂-VASc Scoring (this patient)

Criterion	Points
Age 65–74 years	+1
Female sex	+1
Minimum baseline score	≥2

A score ≥2 in females (equivalent to score ≥1 in males) — oral anticoagulation is indicated

Non-valvular AF: Preferred agents are DOACs (apixaban, rivaroxaban, dabigatran, edoxaban)
Valvular AF (mechanical valve, rheumatic mitral stenosis): warfarin (INR 2–3)

Causes of AF to Consider in This Patient

Category	Examples
Cardiac	Hypertensive heart disease, IHD/ACS, cardiomyopathy, valvular disease, HF
Pulmonary	Pulmonary embolism, pneumonia, COPD exacerbation
Metabolic	Hyperthyroidism, hypokalemia, hypomagnesemia
Other	Sepsis, alcohol (holiday heart), drugs

(Rosen's Emergency Medicine, Box 65.8)

Rate vs. Rhythm Control Strategy

Acute: Rate control is the priority once stability is ensured
Long-term: Rhythm control via catheter ablation (not anti-arrhythmic drugs) is associated with improved outcomes in AF + heart failure (Rosen's; Goldman-Cecil Medicine)
For elderly patients with rate-controlled AF and no significant symptoms, rate control alone is a reasonable long-term strategy

Disposition

Admit if:

Persistent respiratory distress / pulmonary congestion
Ventricular rate not controlled in ED
Ongoing myocardial ischemia (positive troponin, ischemic ECG changes)
New-onset AF with hemodynamic compromise
High-risk features (prior stroke/TIA, CXR pulmonary congestion, long AF duration)

Summary Algorithm

65F — Dyspnea + AF with RVR + ST-T changes
        ↓
Is she UNSTABLE? (hypotensive, severe pulmonary edema, altered mental status)
        ↓                          ↓
       YES                         NO
        ↓                          ↓
Synchronized DC             Investigate cause of AF
cardioversion              (ACS? HF? PE? Thyroid?)
                                   ↓
                       Troponin + Echo + CXR + TSH
                                   ↓
                       Rate control: diltiazem IV
                       (if EF reduced → amiodarone or digoxin)
                                   ↓
                       Anticoagulation (CHA₂DS₂-VASc ≥2 → DOAC)
                                   ↓
                       Serial ECG + troponin → rule out ACS
                                   ↓
                       Consider cardioversion if <48h duration
                       (or TEE-guided if >48h)

Sources: Braunwald's Heart Disease (eTable 66G.3; p. 526) | Tintinalli's Emergency Medicine (pp. 149–151) | Rosen's Emergency Medicine (Box 65.8, pp. 2122–2133) | Goldman-Cecil Medicine

This is a shared conversation. Sign in to Orris to start your own chat.